Palatin Technologies, Inc.

AMEX:PTN

Biotechnology

Healthcare
$9.09 -0.82%

-$0.10 today

Market cap
$236.39M
Beta
0.94
P/E (TTM)
-1.9
EPS (TTM)
-$6.43
52W Low $5.00High $31.00

Volume 0.02M

Average 1.78M

PTN Other Income / Expenses

Net non-operating gains and losses, such as investment results, currency effects, and one-off items.

Palatin Technologies, Inc.AMEX: PTN

Other Income / Expenses · Q3 FY2026 · quarter ended Mar 2026

Other income / expenses growth accelerates

Q3 FY2026 other income / expenses of $148.01K rose 8323.8% year over year, ahead of the +44.6% change in trailing-twelve-month other income / expenses. Sequentially, it rose 128.8% from the prior quarter. Over 3 fiscal years it compounded at -26.9% a year.

Context

  • Other income / expenses increased in 2 of the last 3 fiscal years.

What to watch

Whether quarterly growth of +8323.8% holds above the trailing-twelve-month pace of +44.6%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$148.01K+128.8% QoQ
Last fiscal yearJun 2025
$152.59K+102.1% YoY
LTMMar 2026
$270.13K+44.6% YoY
Other Income / Expenses past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+8323.8%——
1 year+102.1%——
3-year CAGR-26.9%——
5-year CAGR——
10-year CAGR——

Other Income / Expenses history

USD · from the income statement

Latest · FY2025
152.59K USD
Year-over-year change
+102.1%

Other Income / Expenses vs competitors

How PTN compares with its peers on the latest reported figures

  • PTN's LTM Mar 2026 other income / expenses of $270.13K is the lowest of the 2 companies compared; the peer median is $11.83M.
  • Its year-over-year change of +44.6% is the lowest of 2, against a peer median of +129.2%.
  • Other income / expenses amounts to 2.1% of revenue for PTN, versus a peer median of 22.0%.
PTN Competitors Peer median
Other Income / Expenses for PTN and competitors
Company Period LTM YoY 3-year CAGR% of revenue
QTTBQ32 Bio Inc.LTM Mar 2026$11.83M +129.2%—22.0%
PTNPalatin Technologies, Inc.LTM Mar 2026$270.13K +44.6%-26.9%2.1%
Peer median (excluding PTN) $11.83M+129.2%—22.0%

Competitors are the stored peer set for PTN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Jun 2021
FY2022
Jun 2022
FY2023
Jun 2023
FY2024
Jun 2024
FY2025
Jun 2025
Revenue(188.6K)1.47M4.85M4.49M0
Cost of Revenue147.84K217.53K418.47K97.64K0
Gross Profit(336.44K)1.25M4.44M4.39M0
Gross Margin178.4%85.2%91.4%97.8%—
Research & Development12.93M21.33M22.63M22.4M14.9M
Selling, General & Admin17.34M16.51M15.29M12.27M7.81M
Operating Expenses33.05M37.84M36.89M26.89M17.46M
Depreciation & Amortization51.12K486.02K288.33K339.08K258.92K
EBITDA(33.52M)(35.68M)(28.4M)(29.38M)(17.03M)
EBITDA Margin17774.4%-2429.9%-585.2%-654.3%—
Operating Income(33.38M)(36.59M)(32.46M)(22.5M)(17.46M)
Operating Margin17701.3%-2491.6%-668.7%-501.0%—
Interest Income23.57K0000
Interest Expense029.68K20.01K17.11K15.03K
Other Income / Expenses(212.39K)390.15K3.75M(7.24M)152.59K
Income Before Tax(33.6M)(36.2M)(28.71M)(29.74M)(17.31M)
Pre-Tax Margin17813.9%-2465.1%-591.5%-662.3%—
Income Tax Expense00(4.67M)00
Net Income(33.57M)(36.2M)(24.04M)(29.74M)(17.31M)
Net Margin17799.2%-2465.1%-495.2%-662.3%—
EPS (Basic)(3.55)(3.79)(2.21)(2.02)(32.15)
EPS (Diluted)(3.55)(3.79)(2.21)(2.02)(32.15)
Weighted Avg Shares9.47M9.54M10.89M14.7M538.35K
Weighted Avg Shares (Diluted)9.47M9.54M10.89M14.7M538.35K

Palatin Technologies, Inc.

AMEX:PTN

Intrinsic Alpha fair value

Locked

Current Price

$9.09

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.